Filana Therapeutics, Inc. Common Stock (FLNA)

• Market cap: $96.6M
• 1 day: 2.56%
• 5 days: -0.5%
• 1 month: -4.31%
• 3 months: -28.57%
• 6 months: -3.85%
• Year to date: -4.31%
• 1 year: -23.37%
• 5 years: -96.21%
• 10 years: -85.79%
• Sector: Healthcare
• Industry: Biotechnology

About: Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A.

Employees: 30